USP9YP34

Across TCGA pan-cancer cohorts, USP9YP34 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated USP9YP34 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher USP9YP34 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP9YP34 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

ESCA, STAD, and SARC are the cancer types where USP9YP34 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	II,III,IV	0.108	0.703	<.001	72	view →
STAD	DFS	Tertile	II,III,IV	1.000	0.378	.034	18	view →
SARC	OS	Tertile	All	0.156	0.767	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

USP9YP34–ESCA (OS)

Open the ESCA breakdown →